SBI Securities Co. Ltd. purchased a new position in VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) during the fourth ...
Hosted on MSN1mon
Should You Invest in the VanEck Pharmaceutical ETF (PPH)?Designed to provide broad exposure to the Healthcare - Pharma segment of the equity market, the VanEck Pharmaceutical ETF (PPH) is a passively managed exchange traded fund launched on 12/20/2011.
Jones Financial Companies Lllp lifted its stake in VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) by 1,827.0% during the fourth quarter, according to its most recent disclosure with the ...
Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. Sign up for the TradeTalks newsletter to receive your weekly dose of trading news, trends and education ...
Find the latest VanEck Pharmaceutical ETF PPH analyst stock forecast, price target, and recommendation trends with in-depth analysis from research reports.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results